Use of GLP-1 and agonists thereof to prevent cardiac myocyte apoptosis

Details for Australian Patent Application No. 2005323063 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Baron, Alain D.; Anderson, Christen

Agent Freehills

Pub. Number AU-B-2005323063

PCT Pub. Number WO2006/073890

Priority 60/639,124 24.12.04 US

Filing date 22 December 2005

Wipo publication date 13 July 2006

Acceptance publication date 27 January 2011

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/073890 Priority application(s): WO2006/073890

27 January 2011 Application Accepted

  Published as AU-B-2005323063

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005323066-Adaptive beam forming with multi-user detection and interference reduction in satellite communication systems and methods

2005323062-Sustained delivery of PDGF using selfassembling peptide nanofibers